Patients with heart failure demonstrated a significantly lower median SFRP5 concentration relative to patients with arrhythmias, with insignificant differences regarding WNT5a and STAT5A expressions between patients with different cardiac diseases (Table 4). This evidence concerns the gene STAT5A and cardiac arrhythmia.